Alatrofloxacin

Alatrofloxacin
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a605016
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration
    Intravenous
    ATC code
    • none
    Legal status
    Legal status
    • Withdrawn
    Pharmacokinetic data
    Bioavailability N/A
    Protein binding 76% (trovafloxacin)
    Metabolism Quickly hydrolyzed to trovafloxacin
    Elimination half-life 9 to 12 hours (trovafloxacin)
    Excretion Fecal and renal (trovafloxacin)
    Identifiers
    CAS Number
    ChemSpider
    UNII
    ChEMBL
    Chemical and physical data
    Formula C26H25F3N6O5
    Molar mass 558.509 g/mol
    3D model (JSmol)
     ☒N☑Y (what is this?)  (verify)

    Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt.[1]

    Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in 2001.

    See also

    References

    1. "Center for Drug Evaluation and Research – Application Number: 020759/020760 – Chemistry Review(s)" (PDF). Food and Drug Administration. Retrieved 29 August 2014.


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.